openPR Logo
Press release

Pelvic Inflammatory Disease Market Regulations and Competitive Landscape Outlook to 2025

12-01-2017 09:34 AM CET | Health & Medicine

Press release from: Transparency Market Research

Pelvic Inflammatory Disease Market Regulations

Pelvic inflammatory disease is an infection in the female reproductive system that includes ovaries, fallopian tubes, uterus, and cervix. Pelvic inflammation is generally caused by a sexually transmitted infection, like gonorrhea and chlamydia. Between 10% to 20% of women with gonococcal infection and 20% to 40% of women with cervical chlamydial infection eventually develop pelvic inflammatory disease. Early diagnosis and treatment are believed to be key elements in the prevention of the condition. If pelvic inflammation is not treated it leads to long term, serious problems such as infertility, Ectopic pregnancy, and chronic pelvic pain.

According to the American Congress of Obstetricians and Gynecologists, more than 1 million women each year are affected by pelvic inflammatory disease in the U.S. Pelvic inflammation is more common among younger women. In the U.S., the cost of treating pelvic inflammatory disease is approximately US$ 2,000 per patient. Women with pelvic inflammatory disease have a 20% chance of developing infertility from tubal scarring. Approximately 13% of women are infertile after a single episode of pelvic inflammatory disease, 25-35% after two episodes, and 50-75% after three or more episodes. The month of April is celebrated as Sexually Transmitted Infection (STI) Awareness month, a time to remind teens and adults of the dangers of STIs and ways to prevent them.

Report Overview and TOC @ https://www.transparencymarketresearch.com/pelvic-inflammatory-disease-market.html

Driving factors such as growing adoption of early diagnosis procedures, changing lifestyles, rapid population growth, growing HIV population, and increasing antibiotics use will fuel the global pelvic inflammatory disease market. According to the U.S. Department of Health & Human Services, approximately 36.7 million people worldwide were living with HIV/AIDS at the end of 2015. Growing awareness among people, increasing research and development, and government initiatives are the other factors which will accelerate the overall pelvic inflammatory disease market growth. On the other hand, side effects of products and a competitive market place may hinder growth.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26990

The pelvic inflammatory disease market has been segmented by disease type, product type, dosage form, distribution channel, and geography. In terms of disease type, the pelvic inflammatory disease market is classified into acute pelvic inflammatory disease, subacute pelvic inflammatory disease, chronic pelvic inflammatory disease, and sexually transmitted pelvic inflammatory disease. In terms of product type, the pelvic inflammatory disease market is classified into Macrolides, Cephalosporins, Tetracyclines, Aminoglycosides, and Others. In terms of dosage form, the market is segmented into parenteral, oral and intramuscular. In terms of distribution channel, the market is classified into hospitals, pharmacies, retail pharmacies, and online pharmacies.

Geographically, the pelvic inflammatory disease market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

for Specific and Customized requirements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=26990

Geographically, North America dominates the pelvic inflammatory disease market. Pelvic inflammatory disease is a serious bacterial infection in the U.S., which affects nearly 1,000,000 women each year and 25% of women with pelvic inflammation must be admitted to the hospital for treatment. Europe is the second largest market for pelvic inflammatory disease. Asia Pacific is expected to expand at a higher rate due to rapid population growth, growing awareness among people, increasing healthcare expenditure, and government initiatives that will drive the pelvic inflammatory disease market in the region. Emerging regions such as Latin America and Middle East & Africa are likely to create ample opportunities for the global pelvic inflammatory disease market. According to Department of STD, AIDS and Viral Hepatitis, in 2015, Brazil had the record number of people undergoing treatment for HIV and AIDS. From 2009 to 2015, the total number of people being treated in the Brazilian Unified Health System (SUS) climbed by 97%, rising from 231 thousand to 455 thousand people.

The major players operating in the pelvic inflammatory disease market include F. Hoffmann-La Roche Ltd, Sanofi S.A., Pfizer Inc., Hospira Inc., Teligent Inc., and GlaxoSmithKline LLC, apart from other significant players worldwide.

Pre Book full report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=28283<ype=S

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pelvic Inflammatory Disease Market Regulations and Competitive Landscape Outlook to 2025 here

News-ID: 840736 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Pelvic

Pelvic Organ Prolapse Devices Market – Forecasts to 2026
As analyzed by GME, the Pelvic Organ Prolapse Devices Market will have a medium growth rate of 3.5% during the forecast period of 2020-2026. Pelvic organ prolapse happens the organs near the pelvis area descend their typical position and lump into the vagina. It tends to be the bladder, bowel, or the uterus. The major cause of the slip of these organs is the weakened tissues and muscles in that
A Route Back to Health? Try Pelvic Wellness Acupuncture
Lafayette, CA - July 16, 2019 - Licensed Lafayette-based acupuncturist Carine Camara is helping clients get back to wellness and overcome health with the launch of the Pelvis Wellness Center. Pelvis Wellness is a holistic acupuncture center in the East Bay area of San Francisco in Lafayette, near Oakland, CA, for mainly reproductive and sexual health solutions. Carine, as a licensed acupuncturist, has developed her own innovative technique, the Pelvis Wellness
Female Pelvic Implants Market Global Entry Strategies 2025
Global Female Pelvic Implants Market: Snapshot Female pelvic in plants is a procedure which is used for treating stress urinary incontinence and pelvic organ prolapse. In the markets today, there are three main types of implants which are used for this procedure. They are, vaginal mesh implants, vaginal Graft in plants, and vaginal sling. Among these, it is the vagina slings which is expected to show promising growth in the years
Female Pelvic Implants Market Demand driven by Players 2025
Global Female Pelvic Implants Market: Overview Female pelvic implants are devices inserted inside a female’s vaginal area to treat some particular disorders such as stress urinary incontinence and pelvic organ prolapse. These vaginal disorders are typically prevalent in aged females, and disrupt the regular life of women to a great extent due to discomfort. The disorders can be treated by surgical processes and with or without prosthetic implants. The primary products
Female Pelvic Implants Market Previse during 2017 - 2025
Global Female Pelvic Implants Market: Overview Female pelvic implants are devices inserted inside a female’s vaginal area to treat some particular disorders such as stress urinary incontinence and pelvic organ prolapse. These vaginal disorders are typically prevalent in aged females, and disrupt the regular life of women to a great extent due to discomfort. The disorders can be treated by surgical processes and with or without prosthetic implants. The primary products
Global Pelvic Electro-stimulators Market Developments and Innovations 2018
Qyresearchreports include new market research report "Global Pelvic Electro-stimulators Market Professional Survey Report 2018" to its huge collection of research reports. A market intelligence report on the global market for Pelvic Electro-stimulators has been added to enable key stakeholders in it to bet right on the market and thus improve their profit margins. The exhaustive report furnishes information on how the market for Pelvic Electro-stimulators will evolve over the course of